Blood transcriptome and clonal T-cell correlates of response and non-response to eltrombopag therapy in a cohort of patients with chronic immune thrombocytopenia.
作者信息
Zhang Haiyu, Zhang Bing M, Guo Xiangqian, Xu Liwen, You Xiaoqing, West Robert B, Bussel James B, Zehnder James L
机构信息
Department of Pathology, School of Medicine, Stanford University, Stanford, CA, USA.
Department of Preventive Medicine, School of Basic Medical Sciences, Henan University, Kaifeng, China.
出版信息
Haematologica. 2020 Mar;105(3):e129-e132. doi: 10.3324/haematol.2019.226688. Epub 2019 Jul 11.
Abstract
摘要
相似文献
1
Blood transcriptome and clonal T-cell correlates of response and non-response to eltrombopag therapy in a cohort of patients with chronic immune thrombocytopenia.一组慢性免疫性血小板减少症患者中，艾曲泊帕治疗反应与无反应的血液转录组及克隆性T细胞相关性
Haematologica. 2020 Mar;105(3):e129-e132. doi: 10.3324/haematol.2019.226688. Epub 2019 Jul 11.
2
Eltrombopag for chronic immune thrombocytopenia.艾曲泊帕用于慢性免疫性血小板减少症。
Lancet. 2016 Jan 23;387(10016):336. doi: 10.1016/S0140-6736(16)00107-0.
3
Eltrombopag for chronic immune thrombocytopenia - Authors' reply.艾曲泊帕用于慢性免疫性血小板减少症——作者回复
Lancet. 2016 Jan 23;387(10016):336-337. doi: 10.1016/S0140-6736(16)00009-X.
4
Eltrombopag for resistant immune thrombocytopenia secondary to chronic lymphocytic leukaemia.艾曲泊帕用于慢性淋巴细胞白血病继发的难治性免疫性血小板减少症。
Intern Med J. 2014 Jul;44(7):697-9. doi: 10.1111/imj.12468.
5
Immune thrombocytopenia in two infant cases managed with eltrombopag.两例使用艾曲泊帕治疗的婴儿免疫性血小板减少症病例
Pediatr Blood Cancer. 2021 Sep;68(9):e29120. doi: 10.1002/pbc.29120. Epub 2021 May 28.
6
Eltrombopag in thrombocytopenia.艾曲泊帕用于血小板减少症。
N Engl J Med. 2008 Mar 6;358(10):1072; author reply 1072-3.
7
A comment on Boyers et al.: "eltrombopag for the treatment of chronic immune or idiopathic thrombocytopenic purpura: a NICE single technology appraisal".对博耶斯等人的评论：“艾曲泊帕用于治疗慢性免疫性或特发性血小板减少性紫癜：英国国家卫生与临床优化研究所单一技术评估”
Pharmacoeconomics. 2013 Jan;31(1):87-9. doi: 10.1007/s40273-012-0003-8.
8
Acute Myocardial Infarction Due to Eltrombopag Therapy in a Patient with Immune Thrombocytopenic Purpura.一名免疫性血小板减少性紫癜患者接受艾曲泊帕治疗后发生急性心肌梗死
Turk J Haematol. 2017 Mar 1;34(1):107-108. doi: 10.4274/tjh.2016.0169. Epub 2016 Dec 12.
9
Eltrombopag in chronic idiopathic thrombocytopenic purpura.艾曲泊帕用于慢性特发性血小板减少性紫癜
Lancet. 2009 Feb 21;373(9664):607-8. doi: 10.1016/S0140-6736(09)60377-9.
10
Thrombopoietin Receptor Agonists: Eltrombopag and Romiplostim for the Treatment of Chronic Immune Thrombocytopenia Purpura.血小板生成素受体激动剂：艾曲泊帕和罗米司亭用于治疗慢性免疫性血小板减少性紫癜
Clin J Oncol Nurs. 2019 Apr 1;23(2):212-216. doi: 10.1188/19.CJON.212-216.
引用本文的文献
1
Refractoriness to eltrombopag in adult primary immune thrombocytopenia: utility of next-generation sequencing techniques.成人原发性免疫性血小板减少症对艾曲泊帕的难治性：新一代测序技术的应用
Blood Vessel Thromb Hemost. 2025 Feb 17;2(3):100061. doi: 10.1016/j.bvth.2025.100061. eCollection 2025 Aug.
2
Immune thrombocytopenia in adolescents and young adults.青少年和青年的免疫性血小板减少症
Front Med (Lausanne). 2025 Mar 26;12:1553936. doi: 10.3389/fmed.2025.1553936. eCollection 2025.
3
Effects of genetic ablation and pharmacological inhibition of HuR on gene expression, iron metabolism, and hormone levels.HuR基因敲除和药物抑制对基因表达、铁代谢及激素水平的影响。
BMC Biol. 2025 Jan 23;23(1):24. doi: 10.1186/s12915-025-02131-z.
4
Identification of metabolism-related key genes as potential biomarkers for pathogenesis of immune thrombocytopenia.鉴定代谢相关关键基因作为免疫性血小板减少症发病机制的潜在生物标志物。
Sci Rep. 2024 Apr 19;14(1):9040. doi: 10.1038/s41598-024-59493-7.
5
Pathogenesis of refractory ITP: Overview.难治性 ITP 的发病机制：概述。
Br J Haematol. 2023 Oct;203(1):10-16. doi: 10.1111/bjh.19083.
6
Diagnosis of immune thrombocytopenia, including secondary forms, and selection of second-line treatment.免疫性血小板减少症的诊断，包括继发性形式，以及二线治疗的选择。
Haematologica. 2022 Sep 1;107(9):2018-2036. doi: 10.3324/haematol.2021.279513.
7
Safety and efficacy of eltrombopag in the treatment of children with immune thrombocytopenia: a Meta analysis.艾曲波帕治疗儿童免疫性血小板减少症的安全性和有效性：Meta 分析。
Zhongguo Dang Dai Er Ke Za Zhi. 2021;23(9):944-950. doi: 10.7499/j.issn.1008-8830.2103070.
8
Elucidating the Mechanism of Action of the Attributed Immunomodulatory Role of Eltrombopag in Primary Immune Thrombocytopenia: An In Silico Approach.阐明艾曲泊帕在原发免疫性血小板减少症中所具有的免疫调节作用的作用机制：一种计算方法。
Int J Mol Sci. 2021 Jun 27;22(13):6907. doi: 10.3390/ijms22136907.
9
Identifying and treating refractory ITP: difficulty in diagnosis and role of combination treatment.识别和治疗难治性 ITP：诊断困难和联合治疗的作用。
Blood. 2020 Feb 13;135(7):472-490. doi: 10.1182/blood.2019003599.
本文引用的文献
1
Methodologic Considerations in the Application of Next-Generation Sequencing of Human TRB Repertoires for Clinical Use.人类TRB库二代测序临床应用中的方法学考量
J Mol Diagn. 2017 Jan;19(1):72-83. doi: 10.1016/j.jmoldx.2016.07.009. Epub 2016 Nov 1.
2
Thrombopoietin receptor agonists shift the balance of Fcγ receptors toward inhibitory receptor IIb on monocytes in ITP.促血小板生成素受体激动剂可使 ITP 患者单核细胞上的 Fcγ 受体的平衡向抑制性受体 IIb 转移。
Blood. 2016 Aug 11;128(6):852-61. doi: 10.1182/blood-2016-01-690727. Epub 2016 Jun 8.
3
Gender and duration of disease differentiate responses to rituximab-dexamethasone therapy in adults with immune thrombocytopenia.性别和疾病持续时间可区分免疫性血小板减少症成人对利妥昔单抗-地塞米松治疗的反应。
Am J Hematol. 2016 Sep;91(9):907-11. doi: 10.1002/ajh.24434. Epub 2016 Jun 20.
4
Time-Dependent Decay of mRNA and Ribosomal RNA during Platelet Aging and Its Correlation with Translation Activity.血小板衰老过程中mRNA和核糖体RNA的时间依赖性衰变及其与翻译活性的相关性
PLoS One. 2016 Jan 25;11(1):e0148064. doi: 10.1371/journal.pone.0148064. eCollection 2016.
5
Successful discontinuation of eltrombopag after complete remission in patients with primary immune thrombocytopenia.在原发性免疫性血小板减少症患者完全缓解后成功停用艾曲泊帕。
Am J Hematol. 2015 Mar;90(3):E40-3. doi: 10.1002/ajh.23900. Epub 2015 Jan 16.
6
Next generation sequencing-based expression profiling identifies signatures from benign stromal proliferations that define stromal components of breast cancer.基于新一代测序的表达谱分析可识别出良性基质增殖的特征，这些特征定义了乳腺癌的基质成分。
Breast Cancer Res. 2013 Dec 17;15(6):R117. doi: 10.1186/bcr3586.
7
Defective regulatory B-cell compartment in patients with immune thrombocytopenia.免疫性血小板减少症患者的调节性 B 细胞缺陷。
Blood. 2012 Oct 18;120(16):3318-25. doi: 10.1182/blood-2012-05-432575. Epub 2012 Aug 2.
8
Genome-wide RNA-seq analysis of human and mouse platelet transcriptomes.人类和小鼠血小板转录组的全基因组 RNA-seq 分析。
Blood. 2011 Oct 6;118(14):e101-11. doi: 10.1182/blood-2011-03-339705. Epub 2011 May 19.
9
Improved regulatory T-cell activity in patients with chronic immune thrombocytopenia treated with thrombopoietic agents.促血小板生成素治疗慢性免疫性血小板减少症患者的调节性 T 细胞活性增强。
Blood. 2010 Nov 25;116(22):4639-45. doi: 10.1182/blood-2010-04-281717. Epub 2010 Aug 5.
10
3'-end sequencing for expression quantification (3SEQ) from archival tumor samples.从存档的肿瘤样本中进行表达定量的 3' 末端测序（3SEQ）。
PLoS One. 2010 Jan 19;5(1):e8768. doi: 10.1371/journal.pone.0008768.
Zotero 插件